Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|February 26, 2020
Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy?Francisco Fernandez-Gomez, Helene Tran, Claire-Marie Dhaenens, et al.
Molecular Neurodegeneration|October 8, 2024
Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer diseaseSylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 5, 2024
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort studyDavid Blum, Emeline Cailliau, Hélène Béhal, et al.
Molecular Psychiatry|June 23, 2026
Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progressionConstance Delaby, Susanna Schraen-Maschke, Claire Paquet, et al.
Neurobiology of Disease|February 19, 2013
Exacerbated CSF abnormalities in younger patients with Alzheimer's diseaseJulien Dumurgier, Audrey Gabelle, Olivier Vercruysse, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2012
Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM StudyAudrey Gabelle, Julien Dumurgier, Olivier Vercruysse, et al.
Biomarkers in Medicine|May 19, 2010
Tau as a biomarker of neurodegenerative diseasesSusanna Schraen-Maschke, Nicolas Sergeant, Claire-Marie Dhaenens, et al.
Expert Review of Proteomics|May 10, 2008
Biochemistry of Tau in Alzheimer's disease and related neurological disordersNicolas Sergeant, Alexis Bretteville, Malika Hamdane, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 1, 2019
Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with Aβ42/40 ratioHélène Pouclet-Courtemanche, Tri-Bao Nguyen, Emilie Skrobala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2012
Intersite variability of CSF Alzheimer's disease biomarkers in clinical settingJulien Dumurgier, Olivier Vercruysse, Claire Paquet, et al.
Pageof 8